2009•Practical Journal of Clinical MedicineRequires access

The clinical observation for the treatment of using doxofylline to bronchail asthma following lung cancer surgery

Gan Chong-zhi

Open publisher page 0 citations

Abstract

Objective To investigate and evaluate the clinical results of doxofylline for bronchail asthma following lung cancer surgery.Methods 87 cases of bronchial asthma patients following lung cancer surgery were randomly divided into doxofylline treatment group(Group A) and aminophylline treatment group(Group B).Clinical symptoms,blood gas index and the incidence rate of adverse reaction were observed and compared.Results The cough,gasp and lung wheezing rale of Group A patients were obviously remitted,and partial pressure of oxygen and partial pressure of carbon dioxide were evidently improved.The total clinical effective rate of Group A was higher than that of Group B,and the incidence rate of adverse reaction such as palpitation,nausea and agrypnia was lower.The disparity between two groups was significant(P 0.05).Conclusions Doxofylline was a safe and effective drug for the treatment to bronchail asthma following lung cancer surgery.

About this research paper

What this paper is about

Objective To investigate and evaluate the clinical results of doxofylline for bronchail asthma following lung cancer surgery.Methods 87 cases of bronchial asthma patients following lung cancer surgery were randomly divided into doxofylline treatment group(Group A) and aminophylline treatment group(Group B).Clinical symptoms,blood gas index and the incidence rate of adverse reaction were observed and compared.Results The cough,gasp and lung wheezing rale of Group A patients were obviously remitted,and partial pressure of oxygen and partial pressure of carbon dioxide were evidently improved.The total clinical effective rate of Group A was higher than that of Group B,and the incidence rate of adverse reaction such as palpitation,nausea and agrypnia was lower.The disparity between two groups was significant(P 0.05).Conclusions Doxofylline was a safe and effective drug for the treatment to bronchail asthma following lung cancer surgery.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate and evaluate the clinical results of doxofylline for bronchail asthma following lung cancer surgery.Methods 87 cases of bronchial asthma patients following lung cancer surgery were randomly divided into doxofylline treatment group(Group A) and aminophylline treatment group(Group B).Clinical symptoms,blood gas index and the incidence rate of adverse reaction were observed and compared.Results The cough,gasp and lung wheezing rale of Group A patients were obviously remitted,and partial pressure of oxygen and partial pressure of carbon dioxide were evidently improved.The total clinical effective rate of Group A was higher than that of Group B,and the incidence rate of adverse reaction such as palpitation,nausea and agrypnia was lower.The disparity between two groups was significant(P 0.05).Conclusions Doxofylline was a safe and effective drug for the treatment to bronchail asthma following lung cancer surgery.

Key concepts: Medicine, Aminophylline, Lung cancer, Asthma, Incidence (geometry), Nausea, Anesthesia, Adverse effect

Related papers

Back to paper searchBrowse research topicsOriginal source
The clinical observation for the treatment of using doxofylline to bronchail asthma following lung cancer surgery — Research Paper | ScholarLens